SmartTRAK reports that results from a recent Leerink MEDACorp survey suggest that the US Spine market may be turning the corner, with hospital administrators reporting slightly improved case volume growth of 0.9% for Q318 vs 0.7% for Q2. This is consistent with Leerink’s intra-quarter checks and conversations at the North American Spine Society (NASS) 2018 Annual Meeting that the market...
Stability in the US and in International Growth
While the Spine market remains sluggish in the US, international sales are picking up the slack. The Q2 WW Spine Hardware market improved nearly 2% during the quarter despite...
Among the many topics covered in the Q218 Spine Market Recap are:
While we saw a slight upturn in the market in Q4, the beginning of 2018 has again revealed the Spine market’s true colors – with a slight decline in the overall market and notable pricing pressures. With -1.9% YoY growth, Stryker’s US Spine revenues were challenged by market softness as well as low-double digit (~10%) price declines across core product lines. K2M management reported ...
SmartTRAK is excited to be attending ISASS18 - The International Society for the Advancement of Spine Surgery - annual meeting, April 11-13 in Toronto, Canada.
Julianne Burns, Senior Analyst, Spine; Christopher McCarthy, VP Corporate Accounts, Orthopedics and Neuro; and Michelle Calderon, Acc't Manager, Orthopedics will be there representing SmartTRAK. Please contact us if you would like a meeting.
SmartTRAK, the leading source of competitive life sciences intelligence used by the top ten global orthopedic & wound care companies, has published its 2017 US Spine Market Recap and Financial Dashboard.
Among the many topics covered in the Q417/FY17 US Spine Market Recap are:
The WW Spine Hardware Market (excluding biologics) was flat in Q317, driven by softer procedure volumes. But Why? SmartTRAK analyzes what’s behind the market slowdown.
By Julianne Burns, Senior Analyst Spine
The WW Spine Hardware market (excluding biologics) was flat in Q317. US Spine Hardware revenues were down very slightly and the US Fusion market was down according to the SmartTRAK Financial Dashboard.
Don Urbanowicz of Urbanowicz Consulting interviews John Pracyk, MD of DePuy Synthes, Adam Wollowick, MD of Stryker Spine, and Bob Kinsella of Kinsella Group regarding trends and transactions in the spine market in a pre-NASS panel discussion entitled “From the Operating Room to the OEM.”
Capital One, BioMedGPS and Kinsella Group sponsored a panel discussion prior to the 2017 NASS meeting covering a variety of topics. The discussion, featured in the excerpt below, focuses on “From the Operating Room to the OEM” with John Pracyk, MD, PhD, MBA, FAANS, FACS, Spine Franchise Medical Leader at DePuy Synthes; Adam Wollowick, MD, MBA, Senior Director of Business Development at Stryker Spine; Bob Kinsella, President of Kinsella Group; and Don Urbanowicz, Principal of Urbanowicz Consulting (Moderator).
SmartTRAK reviews hot topics from the fall Spine meetings and identifies bright spots in an otherwise soft Spine market.
As we look forward to Q4 and year-end results, a busy fall meeting season comes to a close. This year, industry and analysts alike looked eagerly to the Congress of Neurological Surgeons (CNS) and North American Spine Society (NASS) meetings in the hopes of nailing down some of the new, softer dynamics emerging in the Spine market. Q3 results seem to uphold the theory that the market is challenged, but bright spots remain as companies showcased myriad new interbody platforms and materials, and a few new robotics systems.
SmartTRAK's President & CEO Sharon O'Reilly attended DKOU2017, the German Congress of Orthopedic and Trauma Surgery, in Berlin Oct. 24-27, 2017 and uncovered several new and innovative orthopedic, trauma and spine technologies on the exhibit floor.
This week, the SmartTRAK blog is featuring video interviews from DKOU highlighting new companies and products emerging from Europe.
Next up ...
Peter Kohlbecher, Director, Sales & Marketing of Joline GMBH - Quattroplasty: a novel four balloon technique for reducing vertebral compression fractures
Closed-Loop Spinal Cord Stim: The Next Big Thing?
With impressive preliminary data from Saluda Medical’s AVALON trial, and all the big players working on evoked potentials, will closed-loop spinal cord stimulation (#SCS) be the next big thing?